Trials / Completed
CompletedNCT00233363
Exploratory Study for Dry Mouth in Patients With Sjögren's Syndrome
An Exploratory Study of Rebamipide to Evaluate Efficacy and Safety in the Treatment of Dry Mouth in Patients With Sjögren's Syndrome
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Otsuka Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to exploratively investigate the clinical efficacy of rebamipide on dry mouth in patients with Sjögren's syndrome in comparison with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rebamipide |
Timeline
- Start date
- 2005-04-15
- Primary completion
- 2006-01-19
- Completion
- 2006-01-27
- First posted
- 2005-10-05
- Last updated
- 2021-06-04
- Results posted
- 2021-06-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00233363. Inclusion in this directory is not an endorsement.